ORIGINAL RESEARCH
Accepted on 29 Jan 2025
Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children
doi 10.3389/fendo.2025.1505050
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
4,247
Total downloads
13k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 14 Jan 2025
The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014
doi 10.3389/fendo.2024.1499735
- 370 views
ORIGINAL RESEARCH
Published on 13 Jan 2025
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
doi 10.3389/fendo.2024.1506953
- 272 views
ORIGINAL RESEARCH
Published on 05 Dec 2024
Associations of serum folate and vitamin B12 levels with all-cause mortality among patients with metabolic dysfunction associated steatotic liver disease: a prospective cohort study
doi 10.3389/fendo.2024.1426103
- 878 views
ORIGINAL RESEARCH
Published on 21 Nov 2024
Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe
doi 10.3389/fmed.2024.1383112
- 715 views
ORIGINAL RESEARCH
Published on 26 Sep 2024
Predicting cardiometabolic disease in medical students using FibroScan and 30-year Framingham risk scores
doi 10.3389/fmed.2024.1431935
- 2,090 views
ORIGINAL RESEARCH
Published on 25 Sep 2024
Identifying metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus using clinic-based prediction tools
doi 10.3389/fmed.2024.1425145
- 611 views
ORIGINAL RESEARCH
Published on 19 Sep 2024
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study
doi 10.3389/fendo.2024.1451383
- 626 views
REVIEW
Published on 23 May 2024
Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin
doi 10.3389/fendo.2024.1411706
- 1,733 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 May 2024
Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017–2018
doi 10.3389/fendo.2024.1405828
- 2,569 views
- 2 citations
Published in
Frontiers in Endocrinology
- Clinical Diabetes
Impact
- 13kTopic views
- 8,770Article views
- 4,247Article downloads